Letter/Communication
A Leap Forward in Hemophilia A Treatment
NEJM journal watch. Oncology & hematology
07/29/2024
Abstract
Efanesoctocog alfa, a novel factor VIII replacement therapy, emerges as one of the options for improved prophylaxis in pediatric patients with hemophilia A.
Details
- Title: Subtitle
- A Leap Forward in Hemophilia A Treatment
- Creators
- Anjali Sharathkumar
- Resource Type
- Letter/Communication
- Publication Details
- NEJM journal watch. Oncology & hematology
- Publisher
- Massachusetts Medical Society
- ISSN
- 2330-0426
- Language
- English
- Date published
- 07/29/2024
- Academic Unit
- Stead Family Department of Pediatrics; Hematology/Oncology
- Record Identifier
- 9984691556002771
Metrics
9 Record Views